HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Losartan reduces oxidative stress within the rostral ventrolateral medulla of rats with renovascular hypertension.

AbstractBACKGROUND:
Previous studies showed that the microinjection of antioxidants or the overexpression of superoxide dismutase within the rostral ventrolateral medulla (RVLM) reduces hypertension and sympathoexcitation in the 2-kidney, 1-clip (2K-1C) model. In this study, we hypothesized that angiotensin II (ANG II) type 1 receptor (AT1R) is involved in the oxidative stress within the RVLM and contributes to cardiovascular dysfunction in renovascular hypertension.
METHODS:
Losartan (30mg/kg/day, oral gavage) was administered for 7 consecutive days by week 5 after implantation of the clip (gap width = 0.2mm). Mean arterial pressure, baroreflex, and renal sympathetic nerve activity (rSNA) were evaluated. Superoxide production was evaluated by dihydroethidium (DHE) staining within the RVLM and within a control area. Systemic oxidative stress was characterized by measurement of thiobarbituric acid reactive substances (TBARS) and total glutathione (tGSH) in the blood.
RESULTS:
AT1R blockade significantly (P < 0.05) reduced hypertension by approximately 20% (n = 11) and sympathoexcitation to the kidneys by approximately 41% (n = 6) in the 2K-1C rats. Losartan treatment increased the baroreflex sensitivity of rSNA to pressor (67%) and depressor (140%) stimuli in the 2K-1C rats. AT1R blockade caused a significant (66%) reduction in DHE staining within the RVLM but not within the control area, reduced plasma TBARS (from 1.6±0.1 to 1.0±0.1 nmol/ml), and increased tGSH (from 3.4±0.4 to 5.2±0.3 μmol/g Hb) in the 2K-1C group only.
CONCLUSIONS:
Our findings suggest that the beneficial effects of ANG II blockade in renovascular hypertension are partly due to preferential reduction of oxidative stress in the RVLM.
AuthorsErika E Nishi, Cássia T Bergamaschi, Elizabeth B Oliveira-Sales, Karin A Simon, Ruy R Campos
JournalAmerican journal of hypertension (Am J Hypertens) Vol. 26 Issue 7 Pg. 858-65 (Jul 2013) ISSN: 1941-7225 [Electronic] United States
PMID23485486 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Angiotensin II Type 1 Receptor Blockers
  • Thiobarbituric Acid Reactive Substances
  • Superoxide Dismutase
  • Losartan
Topics
  • Angiotensin II Type 1 Receptor Blockers
  • Animals
  • Arterial Pressure (drug effects)
  • Baroreflex (physiology)
  • Disease Models, Animal
  • Hypertension, Renovascular (drug therapy, metabolism, physiopathology)
  • Losartan (therapeutic use)
  • Male
  • Oxidative Stress (drug effects)
  • Rats
  • Rats, Wistar
  • Superoxide Dismutase (biosynthesis, drug effects)
  • Thiobarbituric Acid Reactive Substances (metabolism)
  • Treatment Outcome
  • Ventral Thalamic Nuclei (drug effects, enzymology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: